CTRI/2019/06/019686已完成2 期
Clinical study on the immune enhancing effect of Amalakyadi Rasayan in children
ational Institute of Ayurveda Jaipur0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Children aged from 1-10 years of either sex.
- •2.Children with recurrent respiratory infections.
排除标准
- •1.Subjects suffering from major systemic illness necessitating long term treatment
- •2.Subjects with evidence of malignancy
- •3.Subjects with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S.creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction (asthmatic and COPD patients)
- •4.Co-morbidity like TB, UTI and bleeding disorders etc
- •5.H/o hypersensitivity to any of the trial drug or their ingredients
- •6.Subjects who have completed participation in any other clinical trial during the past six months
研究者
相似试验
尚未招募
2 期
Clinical Study on the immune Enhancing Effect of Nidigdhikadi Leha on Upper Respiratory Tract Infections (URTI)CTRI/2020/08/027386ational Institute of Ayurveda Jaipur
已完成
2 期
To study the effect of Swarnaprashan in reducing the frequency of illness in children by improving the immunity and increasing the body strength.CTRI/2021/05/033713ational Institute of Ayurveda Jaipur Rajasthan30
暂停
1 期
Evaluation of immunological parameters in high risk group of cancer treated with immune-cell therapyJPRN-jRCTc030200090Takimoto Rishu20
暂停
1 期
Evaluation of immunological parameters in high risk group of cancer treated with immune-cell therapyJPRN-jRCTc030200091Takimoto Rishu20
暂停
1 期
Evaluation of immunological parameters in high risk group of cancer treated with immune-cell therapyJPRN-jRCTc030200089Takimoto Rishu20